Vodice, Croatia

Oliver Franković

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Oliver Franković. Retrieved from https://idiyas.com/inventor/oliver-franković

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Oliver Franković

Introduction:

Oliver Franković, based in Vodice, HR, is a talented inventor known for his groundbreaking work in the field of pharmaceuticals. With a notable patent to his name, Oliver's contributions are making waves in the industry.

Latest Patents:

Oliver Franković holds a significant patent for "Polymorphs of Saxagliptin hydrochloride and processes for preparing them." This invention revolves around providing polymorphs of Saxagliptin hydrochloride, innovative processes for their preparation, and the development of pharmaceutical compositions utilizing these polymorphs.

Career Highlights:

Currently affiliated with Teva Pharmaceutical Industries Limited, Oliver Franković showcases a remarkable dedication to his craft within the pharmaceutical sector. His expertise and innovative mindset have been instrumental in advancing the field of pharmaceuticals.

Collaborations:

Throughout his career, Oliver Franković has had the privilege of collaborating with esteemed professionals in the industry. Some of his notable coworkers include Marina Marinković and Marina Ratkaj, who have contributed to the success of projects alongside him.

Conclusion:

Oliver Franković's work stands as a testament to his inventive spirit and commitment to driving progress in the pharmaceutical domain. With a promising patent portfolio and a collaborative approach to innovation, he continues to inspire and shape the future of pharmaceutical research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…